These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 3794453)

  • 1. [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity].
    Matsuoka R; Inoue T; Miyamura K; Mizutani K; Koike S; Mori H; Kigawa T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2037-44. PubMed ID: 3794453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A clinical evaluation of the protective effect of fosfomycin (FOM) against the cis-diamminedichloroplatinum (CDDP)-induced nephrotoxicity].
    Saito M; Masaki T; Kato H; Numasaka K
    Hinyokika Kiyo; 1988 May; 34(5):782-9. PubMed ID: 3051938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary NAG and gamma-GTP activities as indicators of CDDP renal toxicity: effect of fosfomycin on CDDP renal toxicity].
    Yoshida K; Takahashi T; Nakame Y; Saitoh H; Horiuchi S; Kaneoya F; Negishi T
    Hinyokika Kiyo; 1986 Sep; 32(9):1237-45. PubMed ID: 2880486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
    Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prophylactic effect of fosfomycin on CDDP nephrotoxicity].
    Yogi S; Ikeuchi T; Kai Y
    Hinyokika Kiyo; 1989 Apr; 35(4):615-21. PubMed ID: 2735267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase in advanced neuroblastoma patients receiving cis-diamminedichloroplatinum(II).
    Ikeda H; Nagashima K; Okumura H; Takahashi A; Matsuyama S; Nagamachi Y
    Eur J Surg Oncol; 1988 Feb; 14(1):17-20. PubMed ID: 3278937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute change in urinary NAG activity following CDDP administration].
    Yoshida K; Takahashi T; Nakame Y; Saitoh H; Horiuchi S; Kaneoya F; Negishi T
    Hinyokika Kiyo; 1986 Mar; 32(3):369-73. PubMed ID: 3728241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical investigation of cis-platinum nephrotoxicity in 244 cases of primary lung cancer].
    Soejima A; Inoue T; Suzuki M; Waku M; Nakabayashi K; Kitamoto K; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):801-6. PubMed ID: 1479719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of combination chemotherapy with cis-diamminedichloroplatinum (II) (CDDP) on renal function in patients with urogenital malignancies].
    Kawamura J; Hida S; Higashi Y; Yamauchi T; Soeda A; Yoshida O
    Hinyokika Kiyo; 1985 Feb; 31(2):207-21. PubMed ID: 4040315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relation of enzyme distribution in the kidney and increase pattern of urinary N-acetyl-beta-D-glucosaminidase (NAG) and gamma-glutamyl transpeptidase (gamma-GTP) activities following CDDP administration].
    Takahashi T; Yoshida K; Nakame Y; Saitoh H
    Hinyokika Kiyo; 1987 Oct; 33(10):1569-74. PubMed ID: 2895573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of methods for evaluating the nephrotoxicity of cisplatin].
    Suzumori K; Yasui Y; Suzumori K; Yagami Y; Seki T
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2251-6. PubMed ID: 3044273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute nephrotoxicity by CDDP (on tubular damage)].
    Higuchi K; Negoro Y; Suzuki M; Noguchi M; Nakanishi M; Ishihara M; Nakano M
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):85-9. PubMed ID: 1987905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on serum and urinary alpha 1-microglobulin levels as parameter of the renal function--renal function observed after CDDP administration].
    Ujiie T; Maruta H; Ito N
    Hinyokika Kiyo; 1988 May; 34(5):790-6. PubMed ID: 2459938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of bismuth subnitrate on cisplatin toxicity].
    Chen JT; Kurokawa Y; Nakayama K; Saito K; Sakamoto K; Fukuda K; Hirai Y; Hamada T; Fujimoto I; Yamauchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):815-22. PubMed ID: 3298471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antineoplastic therapy and urinary enzymes. Preliminary note on the determination of urinary N-acetyl-beta-D-glucosaminidase in patients treated with cisplatin].
    Crovato E; Salvini R
    Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2255-60. PubMed ID: 6543318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model].
    Ali-Miraftab H; Bourbouze R; Bondiou MT; Percheron F
    Pathol Biol (Paris); 1988 Mar; 36(3):240-4. PubMed ID: 3283687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [NAG (N-acetyl-beta-D-glucosaminidase)--a sensitive marker for disorders of kidney function].
    Skrezek C; Bertermann H; Schulz FP; König B
    Urologe A; 1990 Jan; 29(1):27-31. PubMed ID: 2316078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cisplatin and ovarian carcinoma--early detection of cisplatin-induced nephrotoxicity].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):888-96. PubMed ID: 4040542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
    Minakami H
    Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of urinastatin against nephrotoxicity of cisplatinum].
    Arakawa A; Kato N; Asai H; Yasui Y; Suzumori K; Suzumori K; Yagami Y
    Gan To Kagaku Ryoho; 1990 Nov; 17(11):2229-34. PubMed ID: 2241187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.